Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07501312 · ClinicalTrials.gov registry record · NA
Remote Microphone Performance Comparison in Adults With Hearing Loss
A NA study, sponsored by Sonova.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT07501312: Completed NA study, sponsored by Sonova.
NCT07501312 is a NA study that has completed, run by Sonova. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07501312, a NA study, has completed, sponsored by Sonova.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
This study will compare far-field speech understanding in noise using a hearing aid alone, with using a hearing aid plus a Roger remote microphone. It will also compare the HA+Roger mic to two other manufacturers' hearing aids plus remote mic systems in the same condition.
Primary Outcome
Validated test of speech intelligibility in which participants repeat as many words as they can from a presented list of 20 sentences. Words correct are calculated as a percent correct from the total number of words presented. Higher percentages mean better speech intelligibility.
Interventions
- DEVICE Phonak
- DEVICE Device A
- DEVICE Device B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2026-03-25 |
| Est. Completion | 2026-04-21 |
| Phase | NA |
What the finished NCT07501312 record still lists
NCT07501312 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Phonak is the first listed.
NCT07501312 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07501312 about?
NCT07501312 is a clinical study titled "Remote Microphone Performance Comparison in Adults With Hearing Loss". This study will compare far-field speech understanding in noise using a hearing aid alone, with using a hearing aid plus a Roger remote microphone. It will also compare the HA+Roger mic to two other manufacturers' hearing aids plus remote mic systems in the same condition.
What is the current status of trial NCT07501312?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2026-03-25. Estimated completion is 2026-04-21.
What interventions are being tested in trial NCT07501312?
The interventions under investigation include: Phonak (DEVICE), Device A (DEVICE), Device B (DEVICE).
Who is sponsoring clinical trial NCT07501312?
This trial is sponsored by Sonova, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07501312's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI